{"id":51779,"date":"2025-12-22T20:51:55","date_gmt":"2025-12-22T12:51:55","guid":{"rendered":"https:\/\/flcube.com\/?p=51779"},"modified":"2025-12-22T20:51:56","modified_gmt":"2025-12-22T12:51:56","slug":"minimed-diabetes-files-for-ipo-seeking-nasdaq-listing-as-mmed","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=51779","title":{"rendered":"MiniMed Diabetes Files for IPO, Seeking Nasdaq Listing as MMED"},"content":{"rendered":"\n

Medtronic plc<\/strong> (NYSE:\u202fMDT<\/a>) announced that its diabetes business, which will operate under the name MiniMed<\/strong>, filed a Form S-1 registration statement<\/strong> with the U.S. Securities and Exchange Commission (SEC)<\/strong> for a proposed initial public offering (IPO)<\/strong>. MiniMed intends to list on the Nasdaq Global Select Market<\/strong> under the ticker \u201cMMED.\u201d<\/strong> The number of shares and price range have not yet been determined.<\/p>\n\n\n\n

IPO Filing Details<\/h2>\n\n\n\n
Item<\/th>Details<\/th><\/tr><\/thead>
Filing Date<\/strong><\/td>22\u202fDec\u202f2025<\/td><\/tr>
Form<\/strong><\/td>SEC Form S-1<\/td><\/tr>
Business<\/strong><\/td>MiniMed (Medtronic\u2019s diabetes division)<\/td><\/tr>
Exchange<\/strong><\/td>Nasdaq Global Select Market<\/td><\/tr>
Ticker<\/strong><\/td>MMED (proposed)<\/td><\/tr>
Shares Offered<\/strong><\/td>To be determined<\/td><\/tr>
Price Range<\/strong><\/td>To be determined<\/td><\/tr>
Parent<\/strong><\/td>Medtronic plc (NYSE:\u202fMDT)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Company Mission & Strategy<\/h2>\n\n\n\n
Focus Area<\/th>Description<\/th><\/tr><\/thead>
Mission<\/strong><\/td>Make diabetes more predictable, allowing patients to live life to the fullest through advanced technology and “always\u2011on” support<\/td><\/tr>
Technology<\/strong><\/td>Next\u2011generation CGM sensors, intelligent dosing systems, AI\u2011driven insights<\/td><\/tr>
Ecosystem<\/strong><\/td>Comprehensive platform for intensive insulin management with customer experience at core<\/td><\/tr>
Listing Rationale<\/strong><\/td>Unlock value, enable independent capital allocation, accelerate innovation<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Strategic Context<\/h2>\n\n\n\n